Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-03-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
独立董事关于2019年度日常关联交易预计事项的事前认可意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from independent directors regarding the anticipated related party transactions for the fiscal year 2019. It references compliance with stock exchange listing rules and company bylaws, and it is a pre-approval opinion submitted to the board of directors. The document is short (842 characters) and does not contain financial statements or detailed financial data. It is not an annual report, audit report, or financial report but rather a governance-related statement about related party transactions. This fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories.
2019-03-25 Chinese
关于召开2018年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2018 Annual General Meeting (AGM) of 三诺生物传感股份有限公司, including the date, time, location, agenda items, voting procedures, and registration details. It references the 2018 Annual Report and other reports to be discussed at the meeting but does not contain the reports themselves. The document is a formal announcement inviting shareholders to attend and vote at the AGM, consistent with the definition of AGM Information (AGM-R). The length and content confirm it is not a brief announcement or a report publication notice but a full AGM notice with attachments related to voting and attendance. Therefore, the correct classification is AGM Information (AGM-R).
2019-03-25 Chinese
关于使用闲置自有资金购买低风险理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company SanNuo Biological Sensor Co., Ltd. regarding the use of idle self-owned funds to purchase low-risk financial products. It details the investment purpose, amount, types of products, risk analysis, decision-making procedures, and opinions from independent directors and the supervisory board. The document is a formal announcement about a capital management decision and does not contain financial statements, earnings data, or detailed financial reports. It is not a report itself but an announcement of a financing or capital use activity. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2322 characters, which is relatively short and consistent with an announcement rather than a full report.
2019-03-25 Chinese
关于公司及子公司向商业银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company SanNuo Bio-Sensor Co., Ltd. regarding the application for a comprehensive credit facility from commercial banks. It details the board meeting resolution to apply for a credit limit of 500 million RMB and authorizes the legal representative to handle related credit business within this limit. The document is short (766 characters) and focuses on financing activities, specifically credit facilities and banking arrangements. There is no financial statement, earnings data, or detailed report content. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising and financing activities.
2019-03-25 Chinese
关于2019年度日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the fiscal year 2019. It includes descriptions of the related parties, transaction types, estimated amounts, pricing principles, and independent directors' opinions. The content focuses on the company's operational and financial dealings with related entities, including procurement and sales transactions, and compliance with regulatory rules. There is no indication that this is a full annual report, audit report, earnings release, or other financial statement. Instead, it is a regulatory announcement about related party transactions, which is a common type of regulatory filing in Chinese stock exchanges. The document is about expected related party transactions and their approval, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like Capital/Financing Update or Board/Management Information. The document length is about 5,399 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the best classification is Regulatory Filings (RNS).
2019-03-25 Chinese
2018年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2018 by 三诺生物传感股份有限公司. It extensively discusses the company's internal control environment, risk assessment, control activities, information and communication, and internal supervision. It includes detailed descriptions of internal control policies, procedures, evaluation criteria for control deficiencies, and corrective actions taken. The document is comprehensive and contains substantive content related to internal control evaluation rather than just an announcement or summary. It does not fit the definitions of Annual Report (10-K), Audit Report (AR), or other financial reports but aligns with the nature of an Audit Report / Information (AR) as it focuses on internal control evaluation and audit-related self-assessment. Therefore, the most appropriate classification is Audit Report / Information (AR).
2019-03-25 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.